Hennessy Alan A, Ross R Paul, Devery Rosaleen, Stanton Catherine
TEAGASC, Moorepark Food Research Centre, Fermoy, Co. Cork, Ireland.
Lipids. 2011 Feb;46(2):105-19. doi: 10.1007/s11745-010-3501-5. Epub 2010 Dec 15.
The bioactive properties of the conjugated linoleic acid (CLA) isomers have long been recognised and are the subject of a number of excellent reviews. However, despite this prominence the CLA isomers are not the only group of naturally occurring dietary conjugated fatty acids which have shown potent bioactivity. In a large number of in vitro and in vivo studies, conjugated α-linolenic acid (CLNA) isomers have displayed potent anti-inflammatory, immunomodulatory, anti-obese and anti-carcinogenic activity, along with the ability to improve biomarkers of cardio-vascular health. CLNA isomers are naturally present in high concentrations in a large variety of seed oils but can also be produced in vitro by strains of lactobacilli and bifidobactena through the activity of the enzyme linoleic acid isomerase on α-linolenic acid. In this review, we will address the possible therapeutic roles that CLNA may play in a number of conditions afflicting Western society and the mechanisms through which this activity is mediated.
共轭亚油酸(CLA)异构体的生物活性特性早已得到认可,并且有许多优秀的综述对此进行了探讨。然而,尽管CLA异构体备受关注,但它们并不是唯一一组已显示出强大生物活性的天然存在的膳食共轭脂肪酸。在大量的体外和体内研究中,共轭α-亚麻酸(CLNA)异构体表现出强大的抗炎、免疫调节、抗肥胖和抗癌活性,同时还具有改善心血管健康生物标志物的能力。CLNA异构体天然大量存在于各种种子油中,但也可以通过乳酸菌和双歧杆菌菌株中脂肪酸异构酶对α-亚麻酸的作用在体外产生。在这篇综述中,我们将探讨CLNA在困扰西方社会的多种病症中可能发挥的治疗作用,以及介导这种活性的机制。